Your browser doesn't support javascript.
loading
A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma.
DeStefano, Vincent M; Wada, Masayuki; Pinz, Kevin G; Assi, Rita; Zhang, Hongyu; Wang, Weijia; Zhang, Wenli; Shah, Darshi; Ma, Yupo; Salman, Huda.
Affiliation
  • DeStefano VM; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA.
  • Wada M; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA.
  • Pinz KG; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA.
  • Assi R; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Zhang H; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Wang W; Department of Advanced Diagnostic and Clinical Medicine, Zhongshan People's Hospital, Zhongshan, People's Republic of China.
  • Zhang W; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Shah D; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA.
  • Ma Y; Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA.
  • Salman H; Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Clin Transl Med ; 14(7): e1743, 2024 Jul.
Article in En | MEDLINE | ID: mdl-39039937

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Antigens, CD20 / Antigens, CD19 / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Clin Transl Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Antigens, CD20 / Antigens, CD19 / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Clin Transl Med Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States